Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinkai Kujiang Tiaoshu Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by Wangjing Hospital of China Academy of Chinese Medical Sciences. It is specifically designed for the treatment of chronic atrophic gastritis (CAG). The decoction follows the TCM therapeutic principle of "Xinkai Kujiang" (Acrid Opening and Bitter Down-draining), which involves using acrid herbs to disperse cold and bitter herbs to clear heat and drain downward, thereby harmonizing the stomach and regulating the "pivot" (Tiaoshu) of the middle jiao. It is currently being evaluated in clinical trials to assess its efficacy in improving gastric mucosal atrophy and clinical symptoms in patients with CAG.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xinkai kujiang tiaoshu decoction.